NCT04557826View on ClinicalTrials.gov

Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

September 23, 2020

Study Completion Date

December 7, 2020

Conditions
Respiratory Tract Infections
Interventions
DEVICE

RD19

Experimental device that uses safe electromagnetic energy to stimulate the proximal repository of respiratory tract infectious disease pathogens

Trial Locations (1)

27612

Carolina Phase I, Raleigh

All Listed Sponsors
lead

EmitBio Inc.

INDUSTRY

NCT04557826 - Acute Safety and Acceptability Study of Experimental Device RD19 for Protection From Human Respiratory Disease Pathogens | Biotech Hunter | Biotech Hunter